Answers are grounded in this paper and cite their sources.
Literature analysis on antiestrogens and aromatase inhibitors for fertility preservation in cancer patients shows vital insights.
Modern cancer treatments, including surgical interventions, chemotherapy and radiation therapy, often adversely affect reproductive function in women of childbearing age. This makes fertility preservation methods, particularly controlled ovarian stimulation, especially relevant. The article presents a comparative analysis of antiestrogens (Tamoxifen) and aromatase inhibitors (Letrozole) for ovulation induction in cancer patients. The efficacy, safety and specific features of these drugs in the context of fertility preservation are examined.
No takes yet. Share an insight, caveat, or question.
Kiseleva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: